|Title:||Robot-Assisted Lung Volume Reduction Surgery in Management of Severe Emphysematous Disease: A Case Series|
|Author(s):||N Hallinan, M Aladaileh, D Eaton|
|Institution:||Mater Misericordiae University Hospital|
|Poster:||Click to view poster|
|Abstract:||Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory disease of the airways, alveoli and pulmonary microvasculature1. In selected patients, lung volume reduction surgery (LVRS) has been shown to improve lung function and quality of life2. Minimally invasive techniques have become standard of care, offering distinct benefits over thoracotomy. We present a case series, describing our experience of robot-assisted LVRS. |
A retrospective review of patients who underwent robot-assisted LVRS in a Dublin hospital was carried out to assess morbidity and mortality. Main outcome measures were post-operative length of stay and chest drain duration.
Robot-assisted LVRS was performed in 6 patients between July 2019 and August 2020. The mean age of patients was 56 years (median age 56 years, range 48-63 years). Patients had a mean pre-operative FEV1 of 33%, total lung capacity of 110% and residual volume of 226% of predicted. The median post-operative length of hospital stay was 4.5 days (range 2-8). The median post-operative chest drain duration was 4.5 days (range 3-19). There were no operative, in hospital or 90 day mortalities.
Based on our experience, robot-assisted LVRS appears safe and feasible. Future projects aim to compare post-operative outcomes in robot-assisted versus video-assisted thoroscopic surgery (VATS) LVRS.